Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis.
about
Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysisAntiplatelet agents for cancer treatment: a real perspective or just an echo from the past?The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium
P2860
Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Heparins that block VEGF-A-med ...... but not lymphatic metastasis.
@en
Heparins that block VEGF-A-med ...... but not lymphatic metastasis.
@nl
type
label
Heparins that block VEGF-A-med ...... but not lymphatic metastasis.
@en
Heparins that block VEGF-A-med ...... but not lymphatic metastasis.
@nl
prefLabel
Heparins that block VEGF-A-med ...... but not lymphatic metastasis.
@en
Heparins that block VEGF-A-med ...... but not lymphatic metastasis.
@nl
P2093
P2860
P356
P1433
P1476
Heparins that block VEGF-A-med ...... but not lymphatic metastasis.
@en
P2093
Alexander Thomas Bauer
Anna Desch
Frank Thomas Mayer
Ioannis Karampinis
Julian Koett
Lukas Goertz
Michael K Bohlmann
Stefan Werner Schneider
Viktor Umansky
P2860
P304
68527-68545
P356
10.18632/ONCOTARGET.11832
P407
P577
2016-09-02T00:00:00Z